RGD-FasL induces apoptosis of pituitary adenoma cells

Lukui Chen1, Guohong Zhuang, Wenzhu Li

  • 1Department of Neurosurgery, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, China. neuro_clk@hotmail.com

Insights

RGD-FasL demonstrates cytotoxic effects on pituitary adenoma cells by inducing apoptosis through caspase activation. This suggests RGD-FasL as a potential novel therapeutic for pituitary adenomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Pituitary adenomas are common tumors.
  • Targeted therapies are needed for pituitary adenoma treatment.
  • Fas ligand (FasL) and its receptor Fas are involved in apoptosis.

Purpose of the Study:

  • To investigate the cytotoxic effects of RGD-FasL on pituitary adenoma cell lines (GH3/MMQ/AtT20).
  • To elucidate the underlying molecular mechanisms of RGD-FasL-induced cytotoxicity.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) for Fas/DcR3 mRNA.
  • Flow cytometry for surface protein expression and cell cycle analysis.
  • MTT assay for cytotoxicity and agarose gel electrophoresis for apoptosis.
  • Western blotting for apoptosis-related proteins (caspases, Bcl-2, RANKL, JNK2).

Main Results:

  • RGD-FasL exhibited dose-dependent cytotoxicity against pituitary adenoma cell lines.
  • MMQ and AtT20 cells showed sensitivity to RGD-FasL similar to FasL, while GH3 cells were less sensitive.
  • RGD-FasL induced cell cycle arrest and apoptosis.
  • Increased expression of caspase-8/9/3, RANKL, and JNK2, with decreased Bcl-2 expression, indicated caspase-dependent apoptosis.

Conclusions:

  • RGD-FasL induces apoptosis in pituitary adenoma cells via caspase activation.
  • RGD-FasL shows promise as a novel therapeutic candidate for pituitary adenomas.

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...